Development of adjusted EBITA and EBITA margin
2017 was a successful year. SFS Group generated dynamic sales growth and improved its position in the medical device industry and in the Americas, thanks to the integration of Tegra Medical. Operating profit showed growth despite the impact of extraordinary operating effects.
After identifying the key themes that have a bearing on SFS’s sustainable development, concrete objectives and actions have now been drawn up.